Natco Pharma
BSE: 524816 | NSE: NATCOPHARM | ISIN: INE987B01018 | Pharmaceuticals
 |
 |
Quarterly Results of Natco Pharma |
------------------- in Rs. Cr. ------------------- |
| ||||||||||
|
||||||||||
| Jun '08 | Sep '08 | Dec '08 | Mar '09 | Jun '09 | ||||||
|
||||||||||
| Sales Turnover | 56.51 | 62.19 | 73.85 | 93.52 | 72.87 | |||||
| Other Income | 5.71 | 6.45 | -- | -12.16 | -- | |||||
| Total Income | 62.22 | 68.64 | 73.85 | 81.36 | 72.87 | |||||
| Total Expenses | 47.84 | 51.50 | 54.29 | 59.08 | 54.68 | |||||
| Operating Profit | 8.67 | 10.69 | 19.56 | 34.44 | 18.19 | |||||
| Profit On Sale Of Assets | -- | -- | -- | -- | -- | |||||
| Profit On Sale Of Investments | -- | -- | -- | -- | -- | |||||
| Gain/Loss On Foreign Exchange | -- | -- | -- | -- | -- | |||||
| VRS Adjustment | -- | -- | -- | -- | -- | |||||
| Other Extraordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Total Extraordinary Income/Expenses | 1.41 | 1.55 | 1.00 | 0.18 | -0.08 | |||||
| Tax On Extraordinary Items | -- | -- | -- | -- | -- | |||||
| Net Extra Ordinary Income/Expenses | -- | -- | -- | -- | -- | |||||
| Gross Profit | 14.38 | 17.14 | 19.56 | 22.28 | 18.19 | |||||
| Interest | 3.01 | 3.22 | 4.22 | 3.28 | 3.99 | |||||
| PBDT | 12.78 | 15.47 | 16.34 | 19.18 | 14.12 | |||||
| Depreciation | 2.70 | 2.85 | 3.00 | 1.80 | 3.15 | |||||
| Depreciation On Revaluation Of Assets | -- | -- | -- | -- | -- | |||||
| PBT | 10.08 | 12.62 | 13.34 | 17.38 | 10.97 | |||||
| Tax | 2.40 | 1.42 | 2.06 | 4.80 | 2.90 | |||||
| Net Profit | 7.68 | 11.20 | 11.28 | 12.58 | 8.07 | |||||
| Prior Years Income/Expenses | -- | -- | -- | -- | -- | |||||
| Depreciation for Previous Years Written Back/ Provided | -- | -- | -- | -- | -- | |||||
| Dividend | -- | -- | -- | -- | -- | |||||
| Dividend Tax | -- | -- | -- | -- | -- | |||||
| Dividend (%) | -- | -- | -- | -- | -- | |||||
| Earnings Per Share | 2.74 | 3.99 | 4.02 | 4.49 | 2.87 | |||||
| Book Value | -- | -- | -- | -- | -- | |||||
| Equity | 28.04 | 28.04 | 28.04 | 28.04 | 28.15 | |||||
| Reserves | -- | -- | -- | -- | -- | |||||
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | |||||
| ||||||||||
| Source : Religare Technova | ||||||||||
| Explore Natco Pharma connections | ||||||||||
| ||||||||||
